Li-Yan Lin

426 total citations
20 papers, 310 citations indexed

About

Li-Yan Lin is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Li-Yan Lin has authored 20 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in Li-Yan Lin's work include Kawasaki Disease and Coronary Complications (6 papers), Coronary Artery Anomalies (6 papers) and Liver Disease Diagnosis and Treatment (2 papers). Li-Yan Lin is often cited by papers focused on Kawasaki Disease and Coronary Complications (6 papers), Coronary Artery Anomalies (6 papers) and Liver Disease Diagnosis and Treatment (2 papers). Li-Yan Lin collaborates with scholars based in China, Taiwan and United Kingdom. Li-Yan Lin's co-authors include Ho‐Chang Kuo, Kuender D. Yang, Hong‐Ren Yu, Wei‐Chiao Chang, Suh‐Hang Hank Juo, Yu‐Shiuan Wang, Chiu‐Ping Lee, Chi‐Di Liang, Chien-Fu Huang and Shuguang Li and has published in prestigious journals such as PLoS ONE, Frontiers in Microbiology and Experimental Neurology.

In The Last Decade

Li-Yan Lin

18 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li-Yan Lin China 9 176 174 62 48 43 20 310
Hong Ryang Kil South Korea 12 179 1.0× 140 0.8× 81 1.3× 17 0.4× 95 2.2× 37 354
Mohammad Amin Abbasi Iran 11 88 0.5× 81 0.5× 18 0.3× 26 0.5× 55 1.3× 41 308
Danny Kupka Germany 10 122 0.7× 39 0.2× 115 1.9× 50 1.0× 48 1.1× 20 427
María del Carmen López Castillo United States 9 81 0.5× 108 0.6× 26 0.4× 41 0.9× 86 2.0× 15 377
Ravi K. Bobba United States 11 97 0.6× 75 0.4× 11 0.2× 78 1.6× 65 1.5× 24 274
Waleed Alazmi United States 14 351 2.0× 160 0.9× 19 0.3× 15 0.3× 102 2.4× 31 519
Danica J. Schulte United States 8 301 1.7× 226 1.3× 69 1.1× 21 0.4× 28 0.7× 8 469
Susana Sampaio Portugal 11 57 0.3× 47 0.3× 21 0.3× 34 0.7× 59 1.4× 36 312
Berta Sáez Spain 10 202 1.1× 72 0.4× 28 0.5× 125 2.6× 148 3.4× 38 384
Tankut İlter Türkiye 12 180 1.0× 72 0.4× 13 0.2× 45 0.9× 196 4.6× 41 453

Countries citing papers authored by Li-Yan Lin

Since Specialization
Citations

This map shows the geographic impact of Li-Yan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li-Yan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li-Yan Lin more than expected).

Fields of papers citing papers by Li-Yan Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li-Yan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li-Yan Lin. The network helps show where Li-Yan Lin may publish in the future.

Co-authorship network of co-authors of Li-Yan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Li-Yan Lin. A scholar is included among the top collaborators of Li-Yan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li-Yan Lin. Li-Yan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Chengyou, Zheng‐Yi Zhou, Haibo Wu, et al.. (2025). Superior diagnostic performance of Grocott methenamine silver staining in pulmonary cryptococcosis: a multicenter, large-sample cohort study. Frontiers in Microbiology. 16. 1615057–1615057.
2.
Peng, Yong, Dazhi Jiang, Shunyu Yao, et al.. (2025). Gene-modified animal models of Parkinson's disease. Experimental Neurology. 390. 115287–115287. 1 indexed citations
3.
Guo, Jiaqi, et al.. (2025). Angiostatin: a promising therapeutic target for atopic dermatitis. Archives of Dermatological Research. 317(1). 616–616.
4.
Huang, Lingyi, et al.. (2024). A significant and persistent rise in the global burden of adolescent NAFLD and NASH estimated by BMI. Frontiers in Public Health. 12. 1437432–1437432. 3 indexed citations
5.
Lin, Li-Yan, et al.. (2024). Diagnostic value of liver stiffness measurement combined with risk scores for esophagogastric variceal bleeding in patients with hepatitis B cirrhosis. European Journal of Radiology. 173. 111385–111385. 1 indexed citations
6.
7.
Lin, Li-Yan, et al.. (2023). Genetically elevated bioavailable testosterone level was associated with the occurrence of benign prostatic hyperplasia. Journal of Endocrinological Investigation. 46(10). 2095–2102. 15 indexed citations
8.
Lin, Li-Yan, Shuguang Li, Qiao Xiong, & Hui Wang. (2021). A retrospective study on the combined biomarkers and ratios in serum and pleural fluid to distinguish the multiple types of pleural effusion. BMC Pulmonary Medicine. 21(1). 95–95. 15 indexed citations
10.
Li, Shuguang, Li-Yan Lin, Feifei Zhang, et al.. (2020). A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China. BMC Infectious Diseases. 20(1). 362–362. 12 indexed citations
11.
Hou, Xin, Kelley R. Healey, Erika Shor, et al.. (2019). Novel FKS1 and FKS2 modifications in a high-level echinocandin resistant clinical isolate of Candida glabrata. Emerging Microbes & Infections. 8(1). 1619–1625. 40 indexed citations
12.
Lu, Shin-Yu, et al.. (2016). Dental extraction without stopping single or dual antiplatelet therapy: results of a retrospective cohort study. International Journal of Oral and Maxillofacial Surgery. 45(10). 1293–1298. 31 indexed citations
13.
Lin, Li-Yan, et al.. (2015). Association between the FCGR2A gene H131R polymorphism and risk of Kawasaki disease: a meta-analysis. Genetics and Molecular Research. 14(2). 6256–6264. 6 indexed citations
14.
Chen, Chia‐Hao, Li-Yan Lin, Kuender D. Yang, Kai‐Sheng Hsieh, & Ho‐Chang Kuo. (2012). Kawasaki disease with G6PD deficiency—Report of one case and literature Review. Journal of Microbiology Immunology and Infection. 47(3). 261–263. 8 indexed citations
15.
Lin, Li-Yan, Ying-Jui Lin, Hong‐Ren Yu, et al.. (2012). Comparison of the Laboratory Data Between Kawasaki Disease and Enterovirus After Intravenous Immunoglobulin Treatment. Pediatric Cardiology. 33(8). 1269–1274. 9 indexed citations
16.
Yu, Hong‐Ren, Ho‐Chang Kuo, Lin Wang, et al.. (2012). Different Modulating Effects of Adenosine on Neonatal and Adult Polymorphonuclear Leukocytes. The Scientific World JOURNAL. 2012. 1–7. 8 indexed citations
17.
Kuo, Ho‐Chang, Kuender D. Yang, Suh‐Hang Hank Juo, et al.. (2011). ITPKC Single Nucleotide Polymorphism Associated with the Kawasaki Disease in a Taiwanese Population. PLoS ONE. 6(4). e17370–e17370. 74 indexed citations
18.
Kuo, Ho‐Chang, Ying-Jui Lin, Suh-Hang Hank Juo, et al.. (2011). Lack of Association between ORAI1/CRACM1 Gene Polymorphisms and Kawasaki Disease in the Taiwanese Children. Journal of Clinical Immunology. 31(4). 650–655. 16 indexed citations
19.
Kuo, Ho‐Chang, Hong‐Ren Yu, Suh‐Hang Hank Juo, et al.. (2010). CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children. Journal of Human Genetics. 56(2). 161–165. 63 indexed citations
20.
Lin, Li-Yan, et al.. (1987). HLA antigen distribution and haplotype segregation in Chinese patients with psoriasis.. PubMed. 100(3). 236–41. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026